AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.555
-0.025 (-0.55%)
Aug 14, 2025, 11:39 AM - Market open
AbCellera Biologics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+75.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +53.68% | Aug 8, 2025 |
| Keybanc | Keybanc | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +119.54% | Jul 14, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $5 | Buy | Initiates | $5 | +9.77% | Jul 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $28 → $10 | Strong Buy | Maintains | $28 → $10 | +119.54% | May 16, 2025 |
| Keybanc | Keybanc | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +9.77% | Apr 16, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +119.54% | Feb 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | -12.18% | Jan 8, 2025 |
| Benchmark | Benchmark | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $14 → $12 | Strong Buy | Reiterates | $14 → $12 | +163.45% | Nov 5, 2024 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 20, 2024 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +9.77% | Jul 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +53.68% | May 8, 2024 |
| Benchmark | Benchmark | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 22, 2024 |
| Stifel | Stifel | Strong Buy Maintains $21 → $17 | Strong Buy | Maintains | $21 → $17 | +273.22% | Feb 21, 2024 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +31.72% | Dec 5, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.